Resource: CARE Program (European Institute of Oncology ): Difference between revisions
From Beacon
m (Update categories.) |
m (Update categories.) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 14: | Line 14: | ||
<span style="display:none">Spleen</span> | <span style="display:none">Spleen</span> | ||
<span style="display:none">Leukemia</span> | <span style="display:none">Leukemia</span> | ||
<span style="display:none">isPatientResource</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
<span style="display:none">Lymphatic</span> | |||
<span style="display:none">Lymphoid</span> | |||
<span style="display:none">Lymphoma</span> | |||
<span style="display:none">Hematologic</span> | |||
<span style="display:none">Hematopoietic</span> | |||
<span style="display:none">Myeloma</span> | |||
<span style="display:none">Plasma cell</span> | |||
Latest revision as of 12:11, 14 December 2025
Go back to European Institute of Oncology page
Primary purpose: To provide continuous medical support and 24-hour on-call assistance for patients with hematological malignancies, helping them manage unexpected signs or symptoms and emergencies that may arise due to their disease or treatment.
Cancer areas of interest: C81-C96: Cancers of the blood and immune system. Click here to learn more.
Information: Click here to access.
